Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
26.03.25
/
50%
€105.70
Target price
26.03.26
€170.49
Performance (%)
24.03%
Price
22:26
€131.10
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ currently has a performance of 24.03%. This prediction currently runs until 26.03.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $183.00 to $184.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.25
03.11.25
03.11.25
€155.28
03.11.26
03.11.26
6.37%
22:26
22:26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€132.10
07.08.24
07.08.24
€165.67
07.08.25
07.08.25
-18.89%
08.08.25
08.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
10.07.24
10.07.24
€159.75
10.07.25
10.07.25
-15.30%
11.07.25
11.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.85
20.03.24
20.03.24
€145.64
20.03.25
20.03.25
-21.07%
21.03.25
21.03.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
-7.50%
24.02.25
24.02.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24